Transforming medical innovations currently at the prototype stage into reality to better combat the threat of Emerging Infectious Diseases & AMR

IDCluster’s purpose is to accelerate the market launch of innovative products for patients or to accelerate the use of solutions for public authorities in the two areas of MIE and AMR, by transforming accelerated R&D projects from their prototype stage into reality.

ID360 Platform

IDCluster’s ambition: To be the leading platform in France for data relating to R&D projects in the EID & AMR fields currently underway in France, and for data relating to existing resources in France that can be mobilized to accelerate these projects (expertise and technologies).

In line with France’s National Strategy for Accelerating Emerging Infectious Diseases (SA MIE), coordinated by the Health Innovation Agency, this observatory will address three specific needs:

Continuous monitoring (mapping) of all R&D projects with a TRL higher than 2 to ensure that projects are complementary and that all initiatives are consistent overall.

Updated mapping of available resources in terms of prevention, diagnosis, and treatment technologies in the field of infectious diseases

Updated mapping of available expertise and production infrastructure (GMP, premises, knowledge of production capacities, including in terms of HR, P2, P3 laboratories, A2 A3 animal facilities, etc.).

IDCluster activities

ID360 Platform

Stimulate innovation

Accelerate innovation

Facilitate acceleration